KPTI – karyopharm therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

KPTI

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/4

11:30 am

kpti

Rating for KPTI

Low Report

Rating for KPTI

Report

11/4

11:30 am

kpti

Rating for KPTI

Low Report

Rating for KPTI

Report

10/13

08:07 am

kpti

Karyopharm Therapeutics (NASDAQ:KPTI) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $15.00 price target on the stock.

Medium Report

Karyopharm Therapeutics (NASDAQ:KPTI) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $15.00 price target on the stock.

Report

10/13

06:10 am

kpti

Karyopharm upgraded to Buy from Neutral at H.C. Wainwright

Low Report

Karyopharm upgraded to Buy from Neutral at H.C. Wainwright

Report

10/13

06:10 am

kpti

Karyopharm upgraded to Buy from Neutral at H.C. Wainwright

Low Report

Karyopharm upgraded to Buy from Neutral at H.C. Wainwright

Report

10/9

08:05 am

kpti

Rating for KPTI

Low Report

Rating for KPTI

Report

10/9

08:05 am

kpti

Rating for KPTI

Low Report

Rating for KPTI

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.